Latest Articles
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use - PMLiVE
GSK’s Jemperli receives positive CHMP opinion for expanded endometrial cancer use PMLiVE
Published: Dec. 18, 2024, 12:25 p.m.
Molecular Classification Drives Advances in Endometrial Cancer Treatment - Journal of Clinical Pathways
Molecular Classification Drives Advances in Endometrial Cancer Treatment Journal of Clinical Pathways
Published: Dec. 17, 2024, 3:25 p.m.
GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission - MSN
GSK’s Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission MSN
Published: Dec. 17, 2024, 1:27 p.m.
Endometrioid adenocarcinoma of the colon arising from rare malignant transformation of extra-gonadal endometrioma.
Endometriosis is a common condition with a rare malignant potential. We report a case of a patient with a colon mass who underwent surgery for malignant endometriosis associated cancer.Case: A …
Published: Dec. 17, 2024, midnight
Role of pre-diagnostic reproductive factors on long-term (10 years or greater) survival of epithelial ovarian cancer: The Extreme study.
Several reproductive factors are associated with ovarian cancer risk but the association with survival is less clear. The main aim was to examine the impact of pre-diagnostic reproductive factors on …
Published: Dec. 17, 2024, midnight
GSK's Jemperli receives positive CHMP opinion for endometrial cancer - Investing.com India
GSK's Jemperli receives positive CHMP opinion for endometrial cancer Investing.com India
Published: Dec. 16, 2024, 7:47 p.m.
GSK's Jemperli receives positive CHMP opinion for endometrial cancer - Investing.com
GSK's Jemperli receives positive CHMP opinion for endometrial cancer Investing.com
Published: Dec. 16, 2024, 5:30 p.m.
Different surgical methods of hysterectomy for the management of endometrial cancer: A systematic review and network meta-analysis - Frontiers
Different surgical methods of hysterectomy for the management of endometrial cancer: A systematic review and network meta-analysis Frontiers
Published: Dec. 16, 2024, 4:23 p.m.
Dostarlimab Plus Chemo Earns Positive CHMP Opinion for Expanded Indication in Advanced Endometrial Cancer - OncLive
Dostarlimab Plus Chemo Earns Positive CHMP Opinion for Expanded Indication in Advanced Endometrial Cancer OncLive
Published: Dec. 16, 2024, 4:21 p.m.
GSK’s Jemperli Set for Expanded EMA Approval for Endometrial Cancer - TipRanks
GSK’s Jemperli Set for Expanded EMA Approval for Endometrial Cancer TipRanks
Published: Dec. 16, 2024, 7:45 a.m.
Link copied to clipboard!